SLNCF — Silence Therapeutics Share News
0.000.00%
Last trade - 00:00- $226.72m
- $124.53m
- $43.26m
- 26
- 37
- 24
- 18
REG - Silence Therapeutics - Silence Therapeutics Publication of Annual Report
AnnouncementREG - Silence Therapeutics - Silence Reports Full-year 2020 Results
AnnouncementREG - Silence Therapeutics - Block Listing Application
AnnouncementREG - Silence Therapeutics - Silence presents at Barclays Healthcare Conference
AnnouncementREG - Silence Therapeutics - Notice of Annual Results
AnnouncementREG - Silence Therapeutics - Silence & Mallinckrodt Initiate Work on 3rd Target
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Silence to Partake in March Investor Conferences
AnnouncementREG - Silence Therapeutics - Silence to present at SVB Leerink Conference
AnnouncementREG - Silence Therapeutics - First dosing for SLN360
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Additional Listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Additional listing and Total Voting Rights
AnnouncementREG - Silence Therapeutics - Silence Announces $45m Private Placement
Announcement